Also trades as: IPCALAB.BO (BSE) · $vol 1M
IPCALAB.NS NSE
Ipca Laboratories Limited
1W: -2.7%
1M: -2.2%
3M: +9.2%
YTD: +36.2%
1Y: +42.4%
3Y: +121.2%
5Y: +54.9%
₹1,956.70 ($20.33)
+13.50 (+0.69%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$11.4B
-10.4% ▼
5Y CAGR: +0.9%
Capital Expenditures
$6.6B
+15.4% ▲
5Y CAGR: +12.7%
Free Cash Flow
$4.9B
-2.7% ▼
5Y CAGR: -7.8%
Dividends Paid
$524M
+48.4% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1.4B
+437.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $11.4B | $7.5B | $5.5B | $7.4B | $15.7B |
| Depreciation & Amort. | $2.3B | $2.6B | $3.6B | $4.0B | $4.2B |
| Stock-Based Comp. | $0 | $0 | $31M | $0 | $8M |
| Change in Working Capital | -$2.7B | $490M | -$916M | -$1.8B | -$2.9B |
| Other Non-Cash Items | -$2.4B | -$2.5B | $1.3B | $3.2B | -$5.6B |
| Operating Cash Flow | $8.6B | $8.1B | $9.4B | $12.8B | $11.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$4.8B | -$4.9B | -$4.1B | -$7.8B | -$6.6B |
| Acquisitions (Net) | -$2.4B | -$559M | -$15.4B | $53M | $0 |
| Investment Purchases | -$250M | $0 | $0 | -$1.6B | $0 |
| Investment Sales | $0 | $0 | $648M | $321M | $553M |
| Other Investing | -$1.1B | -$1.7B | $6.0B | $0 | $3.5B |
| Investing Cash Flow | -$8.6B | -$7.2B | -$12.9B | -$8.9B | -$2.5B |
| — Financing Activities — | |||||
| Net Debt Issuance | $5.4B | $6.6B | -$3.6B | -$932M | -$6.0B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1.0B | -$1.0B | -$507M | -$1.0B | -$524M |
| Other Financing | -$121M | -$490M | -$1.4B | -$180M | -$981M |
| Financing Cash Flow | $4.3B | $5.1B | -$5.5B | -$2.1B | -$7.5B |
| Net Change in Cash | $4.3B | $5.9B | -$8.2B | -$420M | $1.4B |
| Cash End of Period | $9.9B | $15.8B | $7.6B | $1.7B | $10.7B |
| Free Cash Flow | $3.8B | $3.1B | $5.3B | $5.0B | $4.9B |